We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

ThromboGenics Announces FDA Acceptance of IND Application

News   Nov 24, 2015

 
ThromboGenics Announces FDA Acceptance of IND Application
 
 
 

RELATED ARTICLES

Compound Combo Shrinks Pancreatic Tumors in Mice Providing Rationale for Clinical Study

News

Scientists have identified a combination of two anti-cancer compounds that were able to shrink pancreatic tumors in mice – supporting the immediate evaluation of the drugs in a clinical trial.

READ MORE

GW Pharmaceuticals Receives Positive NICE Recommendation for EPIDYOLEX (Cannabidiol)

News

GW Pharmaceuticals plc announces that two of its medicines, EPIDYOLEX (cannabidiol) oral solution and Sativex (nabiximols), have been recommended by the UK’s National Institute for Health and Care Excellence (NICE) to receive routine reimbursement from NHS England.

READ MORE

Novel “Fizzy” Patch Could Provide Contraceptive Protection to Women

News

Scientists have created a reversible contraceptive microneedle patch that is able to slowly release the hormone levonorgestrel, through the skin. The study was published November 6, 2019, in Science Advances.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE